Novosanis

Foundation date

12/03/2013

Sector

#Medical Technology

Subsector

Therapeutic areas

Novosanis designs and develops medical devices for a variety of applications, ranging from injection appliances to in vitro diagnostic accessories. Novosanis has two devices in its portfolio: VAX-ID, suited for injections of e.g. vaccines in the dermal layer of the skin and Colli-Pee, suited for collection of first void urine for detection of e.g. sexually transmitted infections and cancer. Novosanis aims to improve health and patient care and to offer a better quality of life through sustainable innovative technologies.

Latest news

  • Waste2Func Video Release: The technology is ready, are we?

    Friday May 24th 2024

  • BIO INX and Readily3D Announce Collaboration to Advance Volumetric Bioprinting with Cutting-edge Gel-MA Based Ink

    Wednesday May 22nd 2024

  • Sequana Medical announces positive outcome of Day 100 meeting with FDA regarding PMA application for alfapump®

    Wednesday May 22nd 2024